How Can Targeting Dimeric Protein Complexes be a Therapeutic Strategy?
Targeting dimeric protein complexes offers a promising approach for cancer therapy. By disrupting the formation or function of these complexes, it is possible to interfere with cancer cell growth and survival. For example, [Monoclonal Antibodies]() like Trastuzumab target the HER2 dimeric complex in breast cancer, preventing its signaling and leading to cancer cell death.
